Drug Profile
Rheumatoid arthritis gene therapy - University of Pittsburgh
Alternative Names: IL-1Ra gene therapyLatest Information Update: 21 Jan 2004
Price :
$50
*
At a glance
- Originator University of Pittsburgh Medical Center
- Class Antirheumatics; Gene therapies
- Mechanism of Action Interleukin 1 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Rheumatoid arthritis